Pharmacist's Letter Canada

June 2022 Issue

Clear Up Confusion About Aspirin for CV Primary Prevention

You'll be asked whether "an aspirin a day" is still good for the heart...

Resources

FAQ: Aspirin for CV Primary Prevention and More

Identify Which Patients May Benefit From Evusheld

You'll hear buzz about Evusheld (tixagevimab/cilgavimab), the first PRE-exposure prophylaxis med for COVID-19, for patients age 12 and up...

Be Familiar With Oral Zeposia for Ulcerative Colitis

Zeposia (ozanimod) will be a new ORAL, once-daily option for moderate to severe ulcerative colitis (UC) in adults...

Be Ready for Questions About Insect and Tick Repellents

Summer will mean more people asking you which bug spray to use...

GO TO FULL ISSUE

SPOTLIGHT ON: PATIENT SAFETY

Ampoules, syringe, & pills

Tips to Improve Insulin Safety

Responding to Med Errors

Dangerous Abbreviations

Editor's Picks

Identify Which Patients May Benefit from Evusheld

Clarify New Heart Failure Terms

Overcome Barriers to Opioid Use for Cancer Pain

CE & Training

Popular Charts